Four people who flew into Delhi from the Netherlands and the UK in the early hours of Wednesday have tested positive for COVID-19 and their samples have been sent for genome sequencing to ascertain if they have the new variant, Omicron, sources said.
All four have been admitted to the LNJP Hospital, where a dedicated ward has been set up for isolating and treating such patients, they added.
“Four flights originating from Amsterdam and London and carrying 1,013 passengers landed at the Indira Gandhi International Airport between 12 night and 6 am. Of these passengers, four have tested positive,” a source said. All four are Indian nationals, he added.
According to the Centre, the countries designated as “at-risk” are the European countries including the UK, South Africa, Brazil, Botswana, China, Mauritius, New Zealand, Zimbabwe, Singapore, Hong Kong and Israel.
Travellers from the “at-risk” countries have to follow additional measures on arrival in India from Tuesday midnight.
Under the new norms, RT-PCR tests are mandatory for passengers arriving from the “at-risk” countries and they will be allowed to leave the airport only after the results come. Also, five per cent of the passengers arriving in flights from other countries will be subject to the test randomly.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022